Management and mechanisms of severe eosinophilic asthma
Rahul Shrimanker
openalex +1 more source
BLOOD EOSINOPHIL COUNT AND FRACTIONAL EXHALED NITRIC OXIDE AS A COMBINED PREDICTOR OF TREATMENT RESPONSE TO BENRALIZUMAB FOR PATIENTS WITH SEVERE, EOSINOPHILIC ASTHMA [PDF]
Rohit Katial +4 more
openalex +1 more source
Extension of mepolizumab injection intervals as potential of saving costs in well controlled patients with severe eosinophilic asthma [PDF]
Georg Bölke +4 more
openalex +1 more source
Real-World Experience with Benralizumab in Patients with Severe Eosinophilic Asthma: A Case Series
Francesco Menzella +8 more
openalex +2 more sources
Eosinophilic Sialodochitis: A Rare Comorbidity of Severe Asthma
O, González +6 more
openaire +2 more sources
Tezepelumab improved chronic eosinophilic pneumonia in severe asthma patients with liver cirrhosis [PDF]
Mizuki Inaba +5 more
openalex +1 more source
Predictive Factors And Treatments Associated with Clinical Remission in Severe Eosinophilic Asthma. [PDF]
Lupia C +10 more
europepmc +1 more source
Comparative efficacy of mepolizumab and benralizumab in severe eosinophilic asthma: a retrospective cohort study. [PDF]
Huang WC +6 more
europepmc +1 more source

